Stocks
Alnylam Pharmaceuticals (ALNY) EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| EBITDA, bln rub | ? | -661.6 | -926.6 | -258.2 | -178.8 | 557.2 | 613.6 | |
| Changes by years, y/y, % | -10% | +40% | -72% | -31% | -412% | |||
Alnylam Pharmaceuticals. EBITDA US GAAP, bln rub
Alnylam Pharmaceuticals. EBITDA US GAAP, changes, %
Alnylam Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Alnylam Pharmaceuticals (ALNY) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 11.5 | 18.8 | 297.2 | 145.2 | 152.4 | 613.6 | |
| Changes by years, y/y, % | -177% | -49% | -593% | -203% | +1 230% | |||
| Changes by quarters, q/q, % | -108% | +64% | +1 478% | -51% | +5% | |||
